Cargando…

Stem Cell-based and Advanced Therapeutic Modalities for Parkinson’s Disease: A Risk-effectiveness Patient-centered Analysis

Treatment of Parkinson's disease (PD), the second most prevalent neurodegenerative disorder, is currently considered a challenging issue since it causes substantial disability, poor quality of life, and mortality. Despite remarkable progress in advanced conventional therapeutic interventions, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salahi, Sarvenaz, Mousavi, Maryam Alsadat, Azizi, Gholamreza, Hossein-Khannazer, Nikoo, Vosough, Massoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890289/ https://www.ncbi.nlm.nih.gov/pubmed/35105291 http://dx.doi.org/10.2174/1570159X20666220201100238

Ejemplares similares

Amniotic Membrane and Its Derivatives: Novel Therapeutic Modalities in Liver Disorders
por: Arki, Mandana Kazem, et al.
Publicado: (2023)

Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders
por: Ghasemzad, Mahsa, et al.
Publicado: (2022)

Novel therapeutic approaches for treatment of COVID-19
por: Hossein-khannazer, Nikoo, et al.
Publicado: (2020)

An update to “novel therapeutic approaches for treatment of COVID-19”
por: Hossein-khannazer, Nikoo, et al.
Publicado: (2021)

Application of Stem Cell-Derived Extracellular Vesicles as an Innovative Theranostics in Microbial Diseases
por: Keshavarz Alikhani, Hani, et al.
Publicado: (2021)

IBD Patients Could Be Silent Carriers for Novel Coronavirus and Less Prone to its Severe Adverse Events: True or False?
por: Ghavami, Shaghayegh Baradaran, et al.
Publicado: (2020)

Umbilical Cord Blood-Derived Monocytes as A Reliable Source of Functional Macrophages for Biomedical Research
por: Torabi, Shukoofeh, et al.
Publicado: (2023)

Novel cell-based therapies in inflammatory bowel diseases: the established concept, promising results
por: Hossein-khannazer, Nikoo, et al.
Publicado: (2021)

Advanced therapeutic modalities in hepatocellular carcinoma: Novel insights
por: Shokoohian, Bahare, et al.
Publicado: (2021)

Regulatory Non-Coding RNAs in Familial Hypercholesterolemia, Theranostic Applications
por: Keshavarz Alikhani, Hani, et al.
Publicado: (2022)

Exosomes for angiogenesis induction in ischemic disorders
por: Moeinabadi‐Bidgoli, Kasra, et al.
Publicado: (2023)

Disulfiram-Loaded Niosomes Reduces Cancerous Phenotypes in Oral Squamous Cell Carcinoma Cells
por: Zangeneh Motlagh, Melika, et al.
Publicado: (2023)

Cost-Analysis of the Different Treatment Modalities in X-Linked Dystonia–Parkinsonism
por: De Roxas, Ranhel C., et al.
Publicado: (2019)

Therapeutic modalities and novel approaches in regenerative medicine for COVID-19
por: Ramezankhani, Roya, et al.
Publicado: (2020)

Utility of Multi-Modal MRI for Differentiating of Parkinson's Disease and Progressive Supranuclear Palsy Using Machine Learning
por: Talai, Aron S., et al.
Publicado: (2021)

Organoids: a novel modality in disease modeling
por: Heydari, Zahra, et al.
Publicado: (2021)

Advancements in Restless Leg Syndrome Management: A Review of Physiotherapeutic Modalities and Their Efficacy
por: Ratnani, Grisha, et al.
Publicado: (2023)

Advances in the Therapeutic Use of Non-Ergot Dopamine Agonists in the Treatment of Motor and Non-Motor Symptoms of Parkinson’s Disease
por: Jing, Xiao-Zhong, et al.
Publicado: (2023)

A Clinical Decision-Making Framework for the Use of Video Gaming as a Therapeutic Modality
por: Espy, Debbie, et al.
Publicado: (2021)

Stem Cell-based Therapeutic and Diagnostic Approaches in Alzheimer's Disease
por: Abdi, Sadaf, et al.
Publicado: (2022)

Editorial: Advanced Neuroimaging of Brain Metastases
por: Vachha, Behroze A., et al.
Publicado: (2021)

Conjugated Linoleic Acid Treatment Attenuates Cancerous features in Hepatocellular Carcinoma Cells
por: Miri-Lavasani, Zohre, et al.
Publicado: (2022)

Mesenchymal Stromal Cell Therapy Improves Refractory Perianal Fistula in Crohn’s Disease: Case Series Clinical Interventional Study
por: Vosough, Massoud, et al.
Publicado: (2022)

Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes
por: Saeed, Usman, et al.
Publicado: (2020)

Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
por: Menon, Sindhu, et al.
Publicado: (2022)

Therapeutic Advances in Multiple Sclerosis
por: Yang, Jennifer H., et al.
Publicado: (2022)

Disruption of Inferior Longitudinal Fasciculus Microstructure in Parkinson's Disease: A Systematic Review of Diffusion Tensor Imaging Studies
por: Haghshomar, Maryam, et al.
Publicado: (2018)

Peri-therapeutic multi-modal hemodynamic assessment and detection of predictors for symptomatic in-stent restenosis after percutaneous transluminal angioplasty and stenting
por: Song, Xiaowen, et al.
Publicado: (2023)

Editorial: Peripheral Immunity in Parkinson's Disease: Emerging Role and Novel Target for Therapeutics
por: Comi, Cristoforo, et al.
Publicado: (2019)

Access to End-of Life Parkinson's Disease Patients Through Patient-Centered Integrated Healthcare
por: Eggers, Carsten, et al.
Publicado: (2018)

Therapeutic Plasticity of Neural Stem Cells
por: Ottoboni, Linda, et al.
Publicado: (2020)

Effect of Cognitive Disability and Ambulation Status on Functioning in Moderate-to-Advanced Parkinson Disease
por: Wang, Chen Yu, et al.
Publicado: (2020)

Advanced Care Planning in Parkinson's Disease: In-depth Interviews With Patients on Experiences and Needs
por: Kurpershoek, Elisabeth, et al.
Publicado: (2021)

Continuous Subcutaneous Apomorphine Infusion in Advanced Parkinson’s Disease: A Systematic Review
por: Gaire, Suman, et al.
Publicado: (2021)

Active Video Games and Low-Cost Virtual Reality: An Ideal Therapeutic Modality for Children With Physical Disabilities During a Global Pandemic
por: Demers, Marika, et al.
Publicado: (2020)

Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models
por: Spathopoulou, Angeliki, et al.
Publicado: (2022)

From the Gut to the Brain and Back: Therapeutic Approaches for the Treatment of Network Dysfunction in Parkinson's Disease
por: Paolone, Giovanna
Publicado: (2020)

Senolytic and senomorphic secondary metabolites as therapeutic agents in Drosophila melanogaster models of Parkinson’s disease
por: Miller, Sean J., et al.
Publicado: (2023)

Genetic and Phenotypic Basis of Autosomal Dominant Parkinson's Disease in a Large Multi-Center Cohort
por: Lesage, Suzanne, et al.
Publicado: (2020)

Editorial: Advances in Therapeutics for Hyperkinetic Movement Disorders
por: Klopstock, Thomas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hoin7f6k91g4g8v1uhs46g7rm0